Pivotal studies on the use of chemotherapies combined with ICIs (e.g., anti‐PD‐L1 antibodies) for ES‐SCLC included only patients with ECOG‐PS 0–1 [8, 9]. The gene discussed is CD274; the disease is small cell lung carcinoma.